Literature DB >> 31399291

A Possible Neurodegeneration Mechanism Triggered by Diabetes.

Aisan Farhadi1, Massoud Vosough2, Jin-San Zhang3, Yaser Tahamtani4, Koorosh Shahpasand5.   

Abstract

Several conditions result in neurodegeneration; among which diabetes mellitus (DM) is of crucial importance. Tau (τ) malfunction is a major pathological process participating in neurodegeneration. Despite extensive considerations, the actual causative link between DM and τ abnormalities remains uncertain thus far. Phosphorylated (p)-τ at Thr-Pro motifs can exist in the two distinct cis and trans conformations. cis is neurotoxic, and is accumulated upon various stress conditions, such as nutrition depletion. We assume that pathogenic cis p-τ is the central mediator of neurodegeneration in DM, and propose why different brain areas give various responses to stress conditions. We herein juxtapose recent approaches in diabetic neurodegeneration and propose a therapeutic target to stop neuronal loss during DM.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cis phosphorylated τ; diabetes mellitus; neurodegeneration

Mesh:

Substances:

Year:  2019        PMID: 31399291     DOI: 10.1016/j.tem.2019.07.012

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  3 in total

1.  High glucose enhances lipopolysaccharide-induced inflammation in cultured BV2 microglial cell line.

Authors:  Hao-Chang Hung; Sheng-Feng Tsai; Shih-Ren Sie; Yu-Min Kuo
Journal:  Immun Inflamm Dis       Date:  2022-05

Review 2.  Which Hyperglycemic Model of Zebrafish (Danio rerio) Suites My Type 2 Diabetes Mellitus Research? A Scoring System for Available Methods.

Authors:  Aria Salehpour; Mohammad Rezaei; Arezoo Khoradmehr; Yaser Tahamtani; Amin Tamadon
Journal:  Front Cell Dev Biol       Date:  2021-03-15

3.  Diabetes Mellitus Is Associated With an Earlier Age of Onset of Huntington's Disease.

Authors:  Pedro Gonzalez-Alegre; Jordan L Schultz; Amy C Ogilvie
Journal:  Mov Disord       Date:  2020-12-24       Impact factor: 10.338

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.